Lido Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.79M | Buy |
41,356
+8,032
| +24% | +$535K | 0.01% | 685 |
|
|
2026
Q1 | $2.09M | Buy |
33,324
+10,125
| +44% | +$705K | 0.01% | 691 |
|
|
2025
Q4 | $1.56M | Sell |
23,199
-67
| -0.3% | -$4.33K | ﹤0.01% | 808 |
|
|
2025
Q3 | $1.57M | Buy |
23,266
+4,865
| +26% | +$385K | ﹤0.01% | 765 |
|
|
2025
Q2 | $1.61M | Sell |
18,401
-59
| -0.3% | -$4.63K | 0.01% | 662 |
|
|
2025
Q1 | $1.26M | Buy |
18,460
+3,365
| +22% | +$275K | 0.01% | 675 |
|
|
2024
Q4 | $1.17M | Sell |
15,095
-2,599
| -15% | -$192K | 0.01% | 701 |
|
|
2024
Q3 | $1.19M | Buy |
17,694
+165
| +0.9% | +$13.5K | 0.01% | 638 |
|
|
2024
Q2 | $1.99M | Sell |
17,529
-43,690
| -71% | -$5.52M | 0.01% | 450 |
|
|
2024
Q1 | $8.49M | Buy |
61,219
+3,351
| +6% | +$421K | 0.05% | 197 |
|
|
2023
Q4 | $7.18M | Buy |
57,868
+1,570
| +3% | +$160K | 0.05% | 215 |
|
|
2023
Q3 | $5.25M | Buy |
56,298
+52,748
| +1,486% | +$5.95M | 0.04% | 231 |
|
|
2023
Q2 | $456K | Buy |
3,550
+528
| +17% | +$63.9K | ﹤0.01% | 777 |
|
|
2023
Q1 | $351K | Sell |
3,022
-89
| -3% | -$9.96K | ﹤0.01% | 824 |
|
|
2022
Q4 | $352K | Sell |
3,111
-211
| -6% | -$23.2K | ﹤0.01% | 748 |
|
|
2022
Q3 | $267K | Sell |
3,322
-1,476
| -31% | -$125K | ﹤0.01% | 794 |
|
|
2022
Q2 | $357K | Sell |
4,798
-958
| -17% | -$87.4K | ﹤0.01% | 654 |
|
|
2022
Q1 | $736K | Buy |
5,756
+532
| +10% | +$58.2K | 0.01% | 474 |
|
|
2021
Q4 | $701K | Buy |
5,224
+196
| +4% | +$28.2K | 0.01% | 505 |
|
|
2021
Q3 | $687K | Buy |
5,028
+632
| +14% | +$79.7K | 0.01% | 485 |
|
|
2021
Q2 | $469K | Buy |
4,396
+72
| +2% | +$6.91K | 0.01% | 565 |
|
|
2021
Q1 | $389K | Sell |
4,324
-348
| -7% | -$32.7K | 0.01% | 569 |
|
|
2020
Q4 | $432K | Buy |
4,672
+116
| +3% | +$10.4K | 0.01% | 517 |
|
|
2020
Q3 | $470K | Sell |
4,556
-1,412
| -24% | -$148K | 0.01% | 395 |
|
|
2020
Q2 | $605K | Sell |
5,968
-36
| -0.6% | -$3.22K | 0.02% | 314 |
|
|
2020
Q1 | $404K | Sell |
6,004
-40
| -0.7% | -$2.49K | 0.02% | 368 |
|
|
2019
Q4 | $331K | Buy |
+6,044
| New | +$287K | 0.01% | 473 |
|
|
2019
Q2 | – | Sell |
-9,648
| Closed | -$287K | – | 551 |
|
|
2019
Q1 | $287K | Sell |
9,648
-264
| -3% | -$9.28K | 0.02% | 401 |
|
|
2018
Q4 | $296K | Buy |
+9,912
| New | +$314K | 0.03% | 313 |
|
Other funds holding DXCM
Lido Advisors's DXCM Position: Q2 2026 in Review
Lido Advisors increased its DexCom (DXCM) stake by 24% in Q2 2026, buying an estimated $535K and bringing the position to 41,356 shares worth $2.79M. The position accounts for 0.01% of the portfolio, ranked #685.
Lido Advisors first reported a position in DXCM in Q4 2018 and has held it in 29 quarters since. The position peaked at $8.49M in Q1 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Lido Advisors held 41,356 shares of DexCom worth $2.79M as of Q2 2026.
- Lido Advisors bought 8,032 DexCom shares in Q2 2026, an estimated $535K.
- DexCom made up 0.01% of Lido Advisors's portfolio in Q2 2026, its #685 holding.
- Lido Advisors first reported a position in DexCom in Q4 2018 and has held it in 29 quarters since.
- Lido Advisors's DexCom position peaked at $8.49M in Q1 2024.
- 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.